International Archives of Medicine Blog
Recombinant proteins in therapeutics
The discovery, development, production and clinical application of recombinant proteins for therapeutic administration has been an area of intensive scientific and medical effort. Today, many recombinant proteins are part of standard therapy while others still remain in a preliminary study phase.
We feature this debate article which discuss this topic at the time that makes an historical review of the treatment of hemophilia.
Recombinant proteins in therapeutics: haemophilia treatment as an example
Antonio Liras
International Archives of Medicine 2008, 1:4 (28 April 2008)
[Abstract] [Provisional PDF]
There is an universal consensus in recommending the use of recombinant proteins in therapeutics, but why are not more widely used? What is your experience and opinion?
All articles published in International Archives of Medicine are open access.
Posted by Diego Camps at 17:18 Comments (2)
We also offer custom production services of recombinant proteins tailored to the customer's needs. In vitro translation is the fastest way of finding the best-expressing construct for a recombinant prokaryotic or eukaryotic protein. From small-scale expression screening to large-scale reactions for structural studies cell-free in vitro translation procedures can streamline a protein project.
Nevertheless recombinant protein technologies still have high production costs. More grants are needed to support large clinical trials for recombinant proteins in many disorders.
Posted by Carlos Vazquez on June 02, 2008 at 01:46 PM BST #
The only problem is that today they are expensive to produce and during next decade we have to improve the technology we use to make it cheaper and cheaper; but there is no doubt: recombinant proteins are the future.
Posted by Y. Teodore on June 16, 2008 at 03:47 PM BST #